Skip to content
Search

Latest Stories

PDA welcome’s High Court judgment strengthening safety rights of locum pharmacists

The Pharmacists' Defence Association (PDA) has welcomed a recent High Court judgment which has extended its support to the locum pharmacists by strengthening their health and safety rights during the Covid-19 pandemic.

The court passed its judgment in response to a petition from the Independent Worker Union of Great Britain (IWGB) which stated that the employment and health and safety law did not adequately protect workers, including locum pharmacists, as they did not receive protection from the concerned during the current pandemic.


The court ruled that the UK had failed properly to implement the EU Health and Safety Framework Directive by confining protection from detriment on health and safety grounds.

In the initial stage of the Covid-19 pandemic, the IWGB received around 144 queries regarding Covid-19 issues, including lack of PPE, failure to implement social distancing and failure to package Covid-19 samples correctly in order to protect medical couriers and they felt vulnerable without these personal protection equipment (PPE).

“Under the EC Directive, the UK should have transposed measures into domestic law to encourage improvements in the health and safety of workers at work and minimum health and safety requirements for the use by workers of PPE in the workplace,” the PDA has said in a release in response to the court judgment.

The IWGB’s argument was that workers should have such protection but the UK domestic legislation, mainly within the Health and Safety at Work etc Act 1974 and the Employment Rights Act 1996, only gave this protection to staff.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less